Esta traducción se está preparando. Mientras tanto, mostramos temporalmente la versión original en inglés.
Negocios · 26/1/20051 min de lectura
Draft Guidance for Industry on Nonclinical Safety Evaluation of Drug Combinations; Availability
Traducción automática local · Idioma original de la fuente
Resumen
The Food and Drug Administration (FDA) is announcing the availability of a draft guidance for industry entitled "Nonclinical Safety Evaluation of Drug Combinations." The guidance provides recommendations on nonclinical approaches to support the clinical study and approval of fixed-dose combination products (FDCs), copackaged products, and adjunctive therapies.
Idioma original de la fuente: Federal Register — Food and Drug AdministrationAbrir el comunicado original →